Relmada Therapeutics, Inc. (RLMD)
6.875
+0.54
(+8.44%)
USD |
NASDAQ |
May 19, 12:33
Relmada Therapeutics Market Cap : 721.12M for May 19, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Theravance Biopharma, Inc. | 840.31M |
| AN2 Therapeutics, Inc. | 160.63M |
| Corcept Therapeutics, Inc. | 6.216B |
| Assertio Holdings, Inc. | 150.35M |
| Johnson & Johnson | 554.43B |
Market Cap Related Metrics
| Price to Book Value | 3.297 |
| Price | 6.875 |
| Earnings Yield | -16.18% |